Capivasertib
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Capivasertib for endometrial neoplasms | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Capivasertib for hereditary sensory and autonomic neuropathies | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Capivasertib for neoplasm metastasis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Capivasertib for prostatic neoplasms | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Capivasertib for uterine cervical neoplasms | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |